Clinical features of Bim deletion polymorphism and its relation with crizotinib primary resistance in Chinese patients with ALK/ROS1 fusion-positive non-small cell lung cancer.
Cancer 2017 Mar .
Zhang Limin, Jiang Tao, Li Xuefei, Wang Yan, Zhao Chao, Zhao Sha, Xi Lei, Zhang Shijia, Liu Xiaozhen, Jia Yijun, Yang Hui, Shi Jinpeng, Su Chunxia, Ren Shengxiang, Zhou Caic
Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens.
The Journal of molecular diagnostics : JMD 2014 Jan 16 (1): 56-67.
Pritchard Colin C, Salipante Stephen J, Koehler Karen, Smith Christina, Scroggins Sheena, Wood Brent, Wu David, Lee Ming K, Dintzis Suzanne, Adey Andrew, Liu Yajuan, Eaton Keith D, Martins Renato, Stricker Kari, Margolin Kim A, Hoffman Noah, Churpek Jane E, Tait Jonathan F, King Mary-Claire, Walsh T